BioWorld - Tuesday, May 5, 2026

mergers and acquisitions

31 items

nice

31 items

multidrug-resistant bacteria

31 items

donanemab

31 items

immune checkpoint inhibitors

31 items

sos1 inhibitors

31 items

omicron variant

31 items

hbv

31 items

daewoong pharmaceutical co. ltd.

31 items

everest medicines ltd.

31 items

fibrogen inc.

31 items

kymera therapeutics inc.

31 items

telehealth

31 items

zimmer biomet holdings inc.

31 items

ema

31 items

myocardial infarction

31 items

real-world evidence

31 items

russia

31 items

sk biopharmaceuticals co. ltd.

31 items

united kingdom

31 items